Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 0.65 % |
3 Month Return | + 37.09 % |
1 Year Return | + 84.43 % |
Market Stats | |
Previous Close | ₹2,673.90 |
Open | ₹2,727.00 |
Volume | 11.95K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹4,422.37Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹4,422.37 Cr |
P/B Ratio | 6.75 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 25.69 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹4,422.37 Cr | 163.84% | 0.51 | NA | NA | |
NA | ₹472.52 Cr | 99.84% | 0.60 | ₹5 Cr | ₹173 Cr | |
NA | ₹181.61 Cr | 64.87% | 0.56 | NA | NA | |
NA | ₹20.73 Cr | 79.9% | 1.86 | NA | NA | |
NA | ₹221.19 Cr | 63.89% | 0.51 | NA | NA |
Organisation | RPG Life Sciences Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for RPG Life Sciences Ltd
RPG Life Sciences is set to announce its Q2 results on November 7, 2024. The stock gained 2.52% on October 31, closing at Rs 2505.45. Year-to-date, shares are up 88%, with impressive long-term returns.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, RPGLIFE has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 3 Years
In the last 3 years, RPGLIFE has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
FII Holding Up
Foreign Institutions have increased holdings from 1.14% to 1.35% in Sep 2024 quarter
MF Holding Up
Mutual Funds have increased holdings from 1.65% to 2.67% in Sep 2024 quarter
Price Rise
In the last 6 months, RPGLIFE stock has moved up by 87.5%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.81% of holdings in Sep 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 21.42% to 20.39% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.81% | 0.00 | |
Foreign Institutions | 1.35% | 17.65 | |
Mutual Funds | 2.67% | 61.58 | |
Retail Investors | 20.39% | ||
Others | 2.78% |
RPG Life Sciences Ltd’s net profit jumped 21.09% since last year same period to ₹26.76Cr in the Q1 2024-2025. On a quarterly growth basis, RPG Life Sciences Ltd has generated 102.11% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, RPG Life Sciences Ltd has declared dividend of ₹16 - translating a dividend yield of 0.60%.
Read More about DividendsBearish
Neutral
Bullish
RPG Life Sciences Ltd is currently in a Bullish trading position according to technical analysis indicators.
RPG Life Sciences Ltd (RPGLIFE) share price today is ₹2653
RPG Life Sciences Ltd is listed on NSE
RPG Life Sciences Ltd is listed on BSE
Today’s traded volume of RPG Life Sciences Ltd(RPGLIFE) is 11.95K.
Today’s market capitalisation of RPG Life Sciences Ltd(RPGLIFE) is ₹4422.37Cr.
RPG Life Sciences Ltd(RPGLIFE | Price |
---|---|
52 Week High | ₹2974.95 |
52 Week Low | ₹1292 |
RPG Life Sciences Ltd(RPGLIFE) share price is ₹2653. It is down -10.82% from its 52 Week High price of ₹2974.95
RPG Life Sciences Ltd(RPGLIFE) share price is ₹2653. It is up 105.34% from its 52 Week Low price of ₹1292
RPG Life Sciences Ltd(RPGLIFE | Returns |
---|---|
1 Day Returns | -20.9% |
1 Month Returns | 0.65% |
3 Month Returns | 37.09% |
1 Year Returns | 84.43% |